ALBUTHERAPEUTICS - Trademark Details
Status: 404 - U.S. registration cancelled because International Registration cancelled in whole or in part
Serial Number
79027066
Registration Number
3324843
Word Mark
ALBUTHERAPEUTICS
Status
404 - U.S. registration cancelled because International Registration cancelled in whole or in part
Status Date
2016-04-10
Filing Date
2006-04-10
Registration Number
3324843
Registration Date
2007-10-30
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form
Typeset
Published for Opposition Date
2007-08-14
Law Office Assigned Location Code
M30
Employee Name
WILLIAMS, IRENE D
Statements
Goods and Services
BIOLOGICAL PREPARATIONS FOR MEDICAL PURPOSES; BIOLOGICAL PRODUCTS, NAMELY, A DRUG DELIVERY SYSTEM COMPRISING ANTIBODIES OR ANTIBODY FRAGMENTS WHICH EXTEND THE EFFECT OF A WIDE VARIETY OF THERAPEUTIC AGENTS, FOR MEDICAL USE AND FOR USE IN MEDICAL TREATMENT; PHARMACEUTICAL PRODUCTS, NAMELY, ALLERGY MEDICATIONS, PAIN MEDICATION, ACNE MEDICATION, ADRENAL HORMONE PREPARATIONS, ANALGESICS, ANAESTHETICS FOR SURGICAL AND NON-SURGICAL USE, ANTACIDS, ANTIARRHYTHMICS, ANTIBACTERIAL PHARMACEUTICALS, ANTIBIOTICS, ANTICOAGULANTS, ANTICONVULSANTS, ANTIDEPRESSANTS, ANTIDIABETIC PREPARATIONS, ANTIEMETICS, ANTIHISTAMINES, ANTIHYPERTENSIVES, ANTIPARASITICS, ANTISEPTICS, ANTITOXIC SERA, ANTIVIRALS, ANTI-ARTHRITIC COMPOSITIONS AND PREPARATIONS, ANTI-CANCER PREPARATIONS, ANTI-COUGH PREPARATIONS, ANTI-DERMOINFECTIVES, ANTI-DIABETIC PHARMACEUTICALS, ANTI-INFECTIVES, ANTI-INFLAMMATORIES, ANTI-SARCOMA PREPARATIONS, ANTI-VENIN, ASPIRIN PREPARATIONS , ANTI- BACTERIAL AND BACTERIOLOGICAL PREPARATIONS FOR MEDICAL PURPOSES, BETA BLOCKERS, BRONCHIAL DILATORS, BURN RELIEF MEDICATION, CARDIOVASCULAR PHARMACEUTICALS, CENTRAL NERVOUS SYSTEM STIMULANTS, CHEMOTHERAPEUTICS, CHLORAMPHENICOL PREPARATIONS, CHOLESTEROL REDUCERS, CHONDROITIN PREPARATIONS, COLD SORE TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, CONTRACEPTIVE PREPARATIONS, COUGH TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, DECONGESTANTS, DERMATOLOGICAL PHARMACEUTICAL PRODUCTS, DIAPHORETICS, DIETARY SUPPLEMENTS, DIURETICS, DRUG DELIVERY AGENTS CONSISTING OF COMPOUNDS THAT FACILITATE DELIVERY OF A WIDE RANGE OF PHARMACEUTICALS, EMETICS, EMMENAGOGUES, ERYTHROMYCIN PREPARATIONS, FERTILITY ENHANCEMENT PREPARATIONS, FOOD SUPPLEMENTS, GASTRO-INTESTINAL TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, GERMICIDES, GLAUCOMA AGENTS, HAIR GROWTH STIMULANTS, HEADACHE TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, HEMORRHOID TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, HORMONE PREPARATIONS, HYDROCORTISONE PREPARATIONS, HYPNOTICS, PHARMACEUTICALS FOR TREATMENT AND/OR PROPHYLAXIS OF ANAPHYLACTIC REACTIONS, INSULIN PREPARATIONS, LACTAGOGUES, MEDICAL DIAGNOSTIC REAGENTS, MEDICATED MOUTH CARE AND TREATMENT PREPARATIONS, MEDICATED SKIN HAIR PREPARATIONS, MEDICATED HAIR CARE PREPARATIONS, MIGRAINE TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, MIXED ANTIBIOTIC PREPARATIONS, MIXED VITAMIN PREPARATIONS, MOTION SICKNESS TREATMENT PREPARATIONS, MUSCLE RELAXANTS, NAIL FUNGUS TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, NASAL SPRAY PREPARATIONS, NAUSEA TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, OPHTHALMIC PREPARATIONS,OPHTHALMOLOGIC PREPARATIONS, PAIN RELIEF MEDICATION, PANCREAS HORMONE PREPARATIONS, ORAL CONTRACEPTIVES, PARASITICIDES FOR MEDICAL USE, PENICILLIN PREPARATIONS, PHARMACEUTICAL ANTITUSSIVE-COLD PREPARATIONS, PHARMACEUTICAL ANTI-ALLERGIC PREPARATIONS AND SUBSTANCES, PHARMACEUTICALS FOR THE TREATMENT OF ERECTILE DYSFUNCTION, ANTICOAGULANTS, ANTIDEPRESSANTS, APPETITE SUPPRESSANTS, ANTI-OBESITY PREPARATIONS, PHARMACEUTICAL PREPARATIONS FOR USE IN CHEMOTHERAPY, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF GOUT, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF HEART RHYTHM DISORDERS, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF INFECTIOUS DISEASES, PHARMACEUTICAL PREPARATIONS ACTING ON THE CENTRAL NERVOUS SYSTEM, PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT AND/OR PROPHYLAXIS OF GASTRO-INTESTINAL DISEASES, PHARMACEUTICAL PREPARATIONS FOR INHALATION FOR THE TREATMENT AND/OR PROPHYLAXIS OF PULMONARY HYPERTENSION, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF CHRONIC PULMONARY DISEASE, PHARMACEUTICAL PREPARATIONS FOR OCULAR OR INTRAOCULAR SURGERY, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF HORMONAL DISORDERS AND THE PREVENTION OF OSTEOPOROSIS, PHARMACEUTICAL PREPARATIONS FOR TREATING AND/OR PROPHYLAXIS OF ALLERGIC RHINITIS AND ASTHMA, PHARMACEUTICAL PREPARATIONS FOR TREATING AND/OR PROPHYLAXIS OF DIABETES, PHARMACEUTICAL PREPARATIONS FOR TREATING AND/OR PROPHYLAXIS OF SKIN DISORDERS, PHARMACEUTICAL PREPARATIONS FOR USE IN DERMATOLOGY, PHARMACEUTICAL PREPARATIONS FOR WOUNDS, PHARMACEUTICAL PREPARATIONS FOR USE IN UROLOGY, BLOOD CLOTTING AID AND DELIVERY SYSTEMS FOR USE IN HUMAN MEDICINE, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF EYE DISEASES AND CONDITIONS, PHARMACEUTICAL PRODUCTS AND PREPARATIONS FOR CHLOASMA, PHARMACEUTICAL PRODUCTS AND PREPARATIONS FOR PREVENTING SKIN BLEMISHES DURING PREGNANCY, PHARMACEUTICAL PRODUCTS FOR OPUTHALMOLOGICAL USE, PHARMACEUTICAL PRODUCTS FOR THE TREATMENT AND/OR PROPHYLAXIS OF BONE DISEASES, PHARMACEUTICAL PRODUCTS FOR THE TREATMENT AND/OR PROPHYLAXIS OF VIRAL AND INFECTIOUS DISEASES, FOR THE TREATMENT AND/OR PROPHYLAXIS OF CANCER, PHARMACEUTICAL PRODUCTS FOR TREATING AND/OR PROPHYLAXIS OF RESPIRATORY DISEASES AND ASTHMA, LIPID LOWERING AGENTS, PSYCHOTROPICS, PITUITARY HORMONE PREPARATIONS, PREPARATIONS FOR THE SUPPRESSION OF HORMONES, PREPARATIONS FOR TREATING AND/OR PROPHYLAXIS OF COLDS,RADIATION SICKNESS TREATING AGENTS, SEDATIVES, STEROIDS, MEDICATIONS FOR USE IN WEIGHT REDUCTION PROGRAMMES, STREPTOMYCIN PREPARATIONS, SYNTHETIC NARCOTICS, SYNTHETIC PEPTIDES FOR PHARMACEUTICAL PURPOSES, TETRACYCLINE PREPARATIONS, THIOLUTIN PREPARATIONS, THREONINE PREPARATIONS, TRANQUILISERS, TUMOUR SUPPRESSING AGENTS, VACCINES, PAIN RELIEF MEDICATION, ALL CONTAINING ANTIBODIES OR ANTIBODY FRAGMENTS FOR MEDICAL USE AND FOR USE IN MEDICAL TREATMENT; MEDICAL PREPARATIONS, NAMELY ANTIBODIES, ANTIBODY FRAGMENTS, PROTEINS, CHIMERIC PROTEINS AND ENZYMES FOR TREATMENT OF PAIN, CENTRAL NERVOUS SYSTEM, INFLAMMATORY, RESPIRATORY, NEOPLASTIC, AUTOIMMUNE, INFECTION, NEUROLOGICAL, CARDIOVASCULAR, AND GASTROINTESTINAL DISEASES AND CONDITIONS, AND CANCER
Goods and Services
RESEARCH AND DEVELOPMENT SERVICES PERFORMED FOR OTHERS IN THE FIELDS OF DRUG DISCOVERY, DRUG DISCOVERY PRODUCTS, PHARMACEUTICALS, MEDICINAL DIAGNOSTICS, AND BIOLOGICAL PRODUCTS; PHARMACEUTICAL AND BIOLOGICAL PRODUCT DEVELOPMENT CONSULTATION; BIOTECHNICAL RESEARCH, CONSULTANCY AND TESTING; LABORATORY RESEARCH AND DEVELOPMENT SERVICES RELATING TO THE PRODUCTION OF ANTIBODIES
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2014-06-06
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2014-06-06
Primary Code
042
Correspondences
Name
GlaxoSmithkline,
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
0893767
International Registration Date
2006-04-10
International Publication Date
2006-10-05
International Renewal Date
2016-04-10
Auto Protection Date
2008-03-14
International Status
102 - Death of IR (Dead as a Result of Non-Renewal, Renunciation or Cancellation by Holder of International Registration)
International Status Date
2016-04-10
Priority Claimed In
True
Priority Claimed Date
2005-10-19
First Refusal In
True
Trademark Events
| Event Date | Event Description |
| 2006-09-14 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| 2006-09-15 | NEW APPLICATION ENTERED IN TRAM |
| 2006-09-19 | ASSIGNED TO EXAMINER |
| 2006-09-19 | NON-FINAL ACTION WRITTEN |
| 2006-09-20 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 2006-09-22 | REFUSAL PROCESSED BY MPU |
| 2006-09-22 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 2006-10-13 | REFUSAL PROCESSED BY IB |
| 2007-03-23 | PAPER RECEIVED |
| 2007-04-25 | ASSIGNED TO LIE |
| 2007-03-23 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2007-04-25 | AMENDMENT FROM APPLICANT ENTERED |
| 2007-05-16 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2007-05-17 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2007-07-25 | NOTICE OF PUBLICATION |
| 2007-08-14 | PUBLISHED FOR OPPOSITION |
| 2007-10-30 | REGISTERED-PRINCIPAL REGISTER |
| 2008-01-30 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 2008-02-04 | FINAL DISPOSITION PROCESSED |
| 2008-02-05 | FINAL DISPOSITION NOTICE SENT TO IB |
| 2009-01-22 | NEW REPRESENTATIVE AT IB RECEIVED |
| 2009-06-05 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 2014-06-06 | CANCELLED SECTION 71 |
| 2015-02-06 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 2015-06-23 | INVALIDATION PROCESSED |
| 2015-06-23 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| 2015-07-10 | TOTAL INVALIDATION PROCESSED BY THE IB |
| 2016-11-10 | DEATH OF INTERNATIONAL REGISTRATION |
| 2016-11-10 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
